Natrix Introduces New Disposable mAb Purification Column
The new column features Natrix’s signature macroporous hydrogel.
Natrix introduced a disposable chromatography device on June 25, 2015 called the Recon HD-Sb. The tool is designed for “the laboratory-scale purification of monoclonal antibodies and other therapeutic biomolecules,” according to a company press release. Although the Recon HD-Sb is a .87 mL-column device, larger columns harnessing the HD-Sb chemistry are currently in development.
The salt-tolerant HD-Sb chemistry includes a cation-exchange membrane augmented with HIC (t-butyl) groups. The product line used Natrix’s three-dimensional, open, macroporous hydrogel, which is purported to increase binding capacity and increase flow rates 10–20 times more than with traditional resins. The HD-Sb chemistry also provides host-cell protein and monomer clearance, as well as aggregate clearance.
Source:
Natrix
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
